title: Regulatory mechanism of body temperature in the central nervous system during the maintenance phase of hibernation in Syrian hamsters: involvement of β-endorphin.
abstract: We have shown previously that intracerebroventricular (icv) injection of naloxone (a non-selective opioid receptor antagonist) or naloxonazine (a selective μ1-opioid receptor antagonist) at the maintenance phase of hibernation arouses Syrian hamsters from hibernation. This study was designed to clarify the role of β-endorphin (an endogenous μ-opioid receptor ligand) on regulation of body temperature (T(b)) during the maintenance phase of hibernation. The number of c-Fos-positive cells and β-endorphin-like immunoreactivity increased in the arcuate nucleus (ARC) after hibernation onset. In contrast, endomorphin-1 (an endogenous μ-opioid receptor ligand)-like immunoreactivity observed on the anterior hypothalamus decreased after hibernation onset. In addition, hibernation was interrupted by icv injection of anti-β-endorphin antiserum at the maintenance phase of hibernation. The mRNA expression level of proopiomelanocortin (a precursor of β-endorphin) on ARC did not change throughout the hibernation phase. However, the mRNA expression level of prohormone convertase-1 increased after hibernation onset. [D-Ala2,N-MePhe4,Gly-ol5] enkephalin (DAMGO, a selective μ-opioid receptor agonist) microinjection into the dorsomedial hypothalamus (DMH) elicited the most marked T(b) decrease than other sites such as the preoptic area (PO), anterior hypothalamus (AH), lateral hypothalamus (LH), ventromedial hypothalamus and posterior hypothalamus (PH). However, microinjected DAMGO into the medial septum indicated negligible changes in T(b). These results suggest that β-endorphin which synthesizes in ARC neurons regulates T(b) during the maintenance phase of hibernation by activating μ-opioid receptors in PO, AH, VMH, DMH and PH.
authors.affiliation: Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, Fukuyama 729-0292, Japan. tamura@fupharm.fukuyama-u.ac.jp
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Tamura
authors.forename: Mitsuteru
authors.initials: M
authors.lastname: Shintani
authors.forename: Hirofumi
authors.initials: H
authors.lastname: Inoue
authors.forename: Mayuko
authors.initials: M
authors.lastname: Monden
authors.forename: Hirohito
authors.initials: H
authors.lastname: Shiomi
mesh_terms: D000701:Analgesics, Opioid / Q000494:pharmacology; D000818:Animals; D001833:Body Temperature Regulation / Q000502:physiology*; D001923:Brain Chemistry / Q000502:physiology; D002452:Cell Count; D002490:Central Nervous System / Q000502:physiology*; D006224:Cricetinae; D020875:Enkephalin, Ala(2)-MePhe(4)-Gly(5)- / Q000494:pharmacology; D006605:Hibernation / Q000502:physiology*; D007031:Hypothalamus / Q000502:physiology; D007035:Hypothermia / Q000503:physiopathology; D007150:Immunohistochemistry; D007276:Injections, Intraventricular; D008647:Mesocricetus; D009842:Oligopeptides / Q000378:metabolism; D016133:Polymerase Chain Reaction; D045664:Proprotein Convertase 1 / Q000096:biosynthesis; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism; D017450:Receptors, Opioid, mu / Q000502:physiology; D001615:beta-Endorphin / Q000502:physiology*
chemical_list: D000701:Analgesics, Opioid; D009842:Oligopeptides; D016760:Proto-Oncogene Proteins c-fos; D017450:Receptors, Opioid, mu; C105293:endomorphin 1; D020875:Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; D001615:beta-Endorphin; D045664:Proprotein Convertase 1